APLSApellis Pharmaceuticals, Inc.Feb 24, 2026Q4 2025
Read transcript →Apellis Pharmaceuticals, Inc. (APLS) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$40.95
-0.07%
Mkt Cap $5.23B
APLSApellis Pharmaceuticals, Inc.Feb 24, 2026APLSApellis Pharmaceuticals, Inc.Oct 30, 2025Q3 2025
Read transcript →APLSApellis Pharmaceuticals, Inc.Aug 2, 2025Q2 2025
Read transcript →APLSApellis Pharmaceuticals, Inc.May 7, 2025Q1 2025
Read transcript →APLSApellis Pharmaceuticals, Inc.Feb 28, 2025Q4 2024
Read transcript →APLSApellis Pharmaceuticals, Inc.Nov 5, 2024Q3 2024
Read transcript →APLSApellis Pharmaceuticals, Inc.Aug 1, 2024Q2 2024
Read transcript →APLSApellis Pharmaceuticals, Inc.May 7, 2024Q1 2024
Read transcript →APLSApellis Pharmaceuticals, Inc.Feb 27, 2024Q4 2023
Read transcript →APLSApellis Pharmaceuticals, Inc.Nov 1, 2023Q3 2023
Read transcript →APLSApellis Pharmaceuticals, Inc.Jul 31, 2023Q2 2023
Read transcript →APLSApellis Pharmaceuticals, Inc.May 6, 2023Q1 2023
Read transcript →APLSApellis Pharmaceuticals, Inc.Nov 8, 2022Q3 2022
Read transcript →APLSApellis Pharmaceuticals, Inc.Aug 8, 2022Q2 2022
Read transcript →APLSApellis Pharmaceuticals, Inc.May 4, 2022Q1 2022
Read transcript →APLSApellis Pharmaceuticals, Inc.Feb 28, 2022Q4 2021
Read transcript →APLSApellis Pharmaceuticals, Inc.Nov 8, 2021Q3 2021
Read transcript →APLSApellis Pharmaceuticals, Inc.Aug 10, 2021Q2 2021
Read transcript →APLSApellis Pharmaceuticals, Inc.Apr 29, 2021Q1 2021
Read transcript →APLSApellis Pharmaceuticals, Inc.Feb 28, 2021Q4 2020
Read transcript →